Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2201
Nuveen Variable Rate Preferred & Income Fund
NPFD
$410M
| $5.01M | ﹤0.01% |
265,957
+6,098
| +2% | +$115K |
2022 Q4
14 quarters
|
|
2202
BitMine Immersion Technologies
BMNR
$12.2B
| $4.95M | ﹤0.01% |
+372,187
| New | +$7.2M |
2026 Q2
0 quarters
|
|
2203
CoinShares PLC
CSHR
$495M
| $4.92M | ﹤0.01% |
+1,306,051
| New | +$6.88M |
2026 Q2
0 quarters
|
|
2204
Inspire Medical Systems
INSP
$1.97B
| $4.92M | ﹤0.01% |
110,285
+6,312
| +6% | +$299K |
2018 Q2
32 quarters
|
|
2205
Edgewise Therapeutics
EWTX
$4.22B
| $4.91M | ﹤0.01% |
120,932
-17,467
| -13% | -$602K |
2021 Q4
18 quarters
|
|
2206
Wipro
WIT
$21.4B
| $4.9M | ﹤0.01% |
2,179,990
+324,765
| +18% | +$691K |
2023 Q3
11 quarters
|
|
2207
SiteOne Landscape Supply
SITE
$4.78B
| $4.9M | ﹤0.01% |
42,824
-178
| -0.4% | -$21.5K |
2016 Q4
38 quarters
|
|
2208
Sprinklr
CXM
$1.58B
| $4.89M | ﹤0.01% |
948,449
+110,777
| +13% | +$589K |
2023 Q2
12 quarters
|
|
2209
Climb Bio
CLYM
$589M
| $4.87M | ﹤0.01% |
+373,445
| New | +$3.86M |
2026 Q2
0 quarters
|
|
2210
Saba Capital Income & Opportunities Fund
BRW
$305M
| $4.86M | ﹤0.01% |
740,127
-52,772
| -7% | -$356K |
2022 Q1
17 quarters
|
|
2211
QuinStreet
QNST
$996M
| $4.86M | ﹤0.01% |
331,636
+40,707
| +14% | +$511K |
2013 Q2
52 quarters
|
|
2212
Tandem Diabetes Care
TNDM
$1.33B
| $4.85M | ﹤0.01% |
321,128
+27,076
| +9% | +$473K |
2018 Q2
32 quarters
|
|
2213
Vir Biotechnology
VIR
$1.91B
| $4.85M | ﹤0.01% |
475,545
+54,213
| +13% | +$516K |
2020 Q4
22 quarters
|
|
2214
Lemonade
LMND
$3.32B
| $4.84M | ﹤0.01% |
74,460
-48,069
| -39% | -$2.81M |
2020 Q3
23 quarters
|
|
2215
Viking Therapeutics
VKTX
$3.48B
| $4.82M | ﹤0.01% |
123,679
+11,340
| +10% | +$366K |
2023 Q2
12 quarters
|
|
2216
Establishment Labs
ESTA
$1.86B
| $4.82M | ﹤0.01% |
+56,212
| New | +$4.04M |
2026 Q2
0 quarters
|
|
2217
PGIM Short Duration High Yield Opportunities Fund
SDHY
$377M
| $4.82M | ﹤0.01% |
293,993
+2,653
| +0.9% | +$42.6K |
2021 Q2
20 quarters
|
|
2218
Metropolitan Bank Holding Corp
MCB
$1.18B
| $4.81M | ﹤0.01% |
48,678
-871
| -2% | -$79K |
2019 Q1
29 quarters
|
|
2219
Entravision Communication
EVC
$562M
| $4.8M | ﹤0.01% |
368,378
+304,972
| +481% | +$2.16M |
2013 Q2
52 quarters
|
|
2220
BlackRock Limited Duration Income Trust
BLW
$454M
| $4.8M | ﹤0.01% |
384,488
+58,589
| +18% | +$735K |
2013 Q2
52 quarters
|
|
2221
Ecovyst
ECVT
$1.11B
| $4.75M | ﹤0.01% |
381,441
+3,986
| +1% | +$54K |
2018 Q1
33 quarters
|
|
2222
World Acceptance Corp
WRLD
$766M
| $4.7M | ﹤0.01% |
20,995
+499
| +2% | +$80.3K |
2013 Q2
52 quarters
|
|
2223
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.2B
| $4.69M | ﹤0.01% |
59,374
-352
| -0.6% | -$27.8K |
2013 Q2
52 quarters
|
|
2224
iShares Core Universal USD Bond ETF
IUSB
$49.9B
| $4.67M | ﹤0.01% |
101,241
+874
| +0.9% | +$40.3K |
2024 Q4
6 quarters
|
|
2225
Western Asset High Income Opportunity Fund
HIO
$313M
| $4.67M | ﹤0.01% |
1,282,493
-72,400
| -5% | -$264K |
2013 Q2
52 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.